The Desmoid Tumor Research Foundation

About DTRF

News & Updates

Stay Up to Date

Join The DTRF Newsletter

Join the Clinicians & Researchers Newsletter

OGSIVEO FDA-Approval Featured Image

Featured News

FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.

Read More about FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.

Filter by:

March 3, 2021

DTRF Awarded The 2021 “Abbey S. Meyers Leadership Award”, A Nord “Rare Impact Award”

Read More about DTRF Awarded The 2021 “Abbey S. Meyers Leadership Award”, A Nord “Rare Impact Award”

March 7, 2019

Big News! DTRF’s First Grant Of 2019 Awarded To The Broad Institute Of MIT And Harvard

Read More about Big News! DTRF’s First Grant Of 2019 Awarded To The Broad Institute Of MIT And Harvard

Clinical Trials

December 20, 2018

DTRF Press Release – DTRF’s Efforts Enable Largest Clinical Study On Desmoid Tumors (And More)

Read More about DTRF Press Release – DTRF’s Efforts Enable Largest Clinical Study On Desmoid Tumors (And More)